Press Release: McGraw Hill, Inc. Exceeds Fiscal Year 2026 Guidance Driven by Re-Occurring Revenue Growth and Delivers Positive Net Income

Dow Jones
06/11

Fiscal Year 2027 Positioned for Revenue Growth and Accelerating Profitability

COLUMBUS, Ohio--(BUSINESS WIRE)--June 11, 2026-- 

McGraw Hill, Inc. (NYSE: MH) ("McGraw Hill" or the "Company"), a leading global provider of education solutions for preK-12, higher education and professional learning, today announced financial results for the fiscal fourth quarter 2026 and year-end March 31, 2026.

Key Fiscal Year 2026 Financial Highlights

   --  Total revenue of $2,102.8 million, an increase of 0.1% year-over-year, 
      driven by strong Higher Education execution, offsetting the anticipated 
      smaller K-12 market opportunity driven by procurement cycles. 
 
   --  Re-occurring revenue of $1,541.0 million, an increase of 5.8% 
      year-over-year, representing more than 73% of total revenue. 
 
   --  Digital revenue of $1,433.6 million, an increase of 5.5% year-over-year 
      amid accelerating student and instructor engagement. 
 
   --  Remaining performance obligation (RPO) of $1,671.4 million as of March 
      31, 2026 demonstrating predictability and visibility into future revenue 
      growth. 
 
   --  GAAP gross profit of $1,701.6 million, representing a GAAP gross profit 
      margin of 80.9%, an increase of over 100 basis points versus prior year. 
 
 
   --  GAAP net income (loss) of $35.3 million, compared to $(85.8) million in 
      the prior-year period. 
 
   --  Adjusted EBITDA(1) of $744.3 million, representing an Adjusted EBITDA 
      margin(1) of 35.4%, an increase of nearly 80 basis points versus prior 
      year. 
 
   --  Reduction of gross debt by $645.6 million, including $50.0 million in 
      the fiscal fourth quarter, at the beginning of the seasonal cash trough. 
 

"McGraw Hill's growth in fiscal year 2026 underscores the strength of our strategy, the speed of our innovation and the depth of trust that we have from the education community," said Philip Moyer, President and Chief Executive Officer of the Company and a member of the Company's Board of Directors. "This past year, we released more new curriculum offerings and learning tools than during any time in our history, reached record engagement levels, and achieved a new high--water mark for customer satisfaction. We have achieved over 7.5 million users of our new AI personalized learning tools and now have an existing base of more than 100 million active student and educator curriculum licenses in over 100 countries. With over 25 billion learning interactions and 190 terabytes of data across our platforms, we are delivering a new generation of precision learning at a global scale that few can match. Equally exciting, we are preparing to pilot our new Agentic AI version of our precision education model, and we intend to be a leader in creating a vibrant 'cloud' knowledge offering in the world of education and learning. Our momentum in fiscal year 2026 positions us well to accelerate growth and expand margins in fiscal year 2027 and beyond."

"Fiscal year 2026 was a transformative year for McGraw Hill--marked by our initial public offering and the growth of our Company, notwithstanding a smaller K-12 market opportunity, expanding profitability and significant debt reduction," said Bob Sallmann, McGraw Hill's Executive Vice President and Chief Financial Officer. "Our disciplined execution delivered results above guidance across revenue, re-occurring revenue and Adjusted EBITDA while strengthening our balance sheet and cash generation. With $646 million in gross debt reduction, we have increased our financial flexibility and expanded margins while simultaneously investing in the business to position the Company for sustained long-term growth. As we enter fiscal year 2027, our focus remains on growth acceleration, operating efficiency and employing a balanced approach to capital allocation as we continue to reduce gross debt, grow the business and strengthen returns."

Fiscal Year 2026 Strategic Highlights

   --  Served over 100 million active student and educator curriculum licenses 
      across more than 100 countries. 
 
   --  Supported tens of thousands of course titles across more than 500 
      subjects. 
 
   --  Captured approximately 25.6 billion learning interactions(2), 
      generating proprietary insights that power precision learning and 
      real--time personalized instruction. 
 
   --  Over 7.5 million users of AI-enabled learning tools with 8 new tools 
      launched over the past two years. 
 
   --  AI Reader generated approximately 57 million learning interactions 
      across approximately 2.4 million students since inception through May, 
      accelerating from approximately 47 million interactions and approximately 
      2.2 million students in fiscal year 2026. 
 
   --  Continued expansion of Evergreen delivery model, which is improving the 
      customer experience and contributing to a record high Spring semester net 
      promoter score for Higher Education. 
 
   --  Launched critical new ELA curriculum that covers grades K-12 and aligns 
      with the Science of Reading. 
 
   --  Piloting a new Agentic AI tool that will make our precision education 
      experience accessible as a trusted AI Agent for both education and 
      non-education customers. 

Fourth Quarter and Fiscal Year 2026 Financial Highlights

 
                            Three Months Ended March 
                                       31,                   Year Ended March 31, 
                           ---------------------------  ------------------------------ 
($ in thousands)             2026           2025           2026            2025 
------------------------    -------       --------       ---------       --------- 
                                   (unaudited) 
                           --------------------------- 
Revenue                    $463,722      $ 473,262      $2,102,781      $2,101,299 
Cost of sales (excluding 
 depreciation and 
 amortization)             $ 74,834      $  78,393      $  401,139      $  422,294 
Operating and 
 administrative expenses   $282,023      $ 292,535      $1,080,250      $1,066,496 
Net income (loss)          $(50,267)     $(156,867)     $   35,320      $  (85,839) 
Adjusted EBITDA (1)        $130,575      $ 131,651      $  744,264      $  726,790 
Net income (loss) margin      (10.8)%        (33.1)%           1.7%           (4.1)% 
Adjusted EBITDA Margin 
 (1)                           28.2%          27.8%           35.4%           34.6% 
Adjusted net income 
 (loss) (1)                $ 61,167      $(328,084)     $  375,459      $  202,350 
 

Fiscal Fourth Quarter Consolidated Financial Highlights

   --  Total revenue of $463.7 million, a decrease of 2.0% year-over-year, 
      reflecting a smaller K--12 market opportunity, partially offset by strong 
      Higher Education performance. 
 
   --  Re-occurring revenue of $373.5 million, a decrease of 3.5% 
      year-over-year. 
 
   --  Digital revenue of $392.7 million, a decrease of 2.1% year-over-year. 
 
 
   --  GAAP gross profit of $388.9 million, representing a GAAP gross profit 
      margin of 83.9%, an increase of nearly 50 basis points versus prior 
      year. 
 
   --  GAAP net income (loss) of $(50.3) million, compared to $(156.9) million 
      in the prior-year period. 
 
   --  Adjusted EBITDA(1) of $130.6 million, representing an Adjusted EBITDA 
      margin(1) of 28.2%, an increase of nearly 40 basis points versus prior 
      year. 

Fiscal Fourth Quarter and Full Year Segment Highlights

Higher Education

   --  Record high market share achieved, according to MPI. 
 
   --  Fiscal Year 2026 revenue totaled $879.0 million, an increase of 12.3% 
      year-over-year, while fiscal fourth quarter revenue grew 1.6% 
      year-over-year supported by share gains, pricing favorability and 
      beneficial enrollment trends. 
 
   --  Fiscal Year 2026 re-occurring revenue totaled $734.4 million, an 
      increase of 10.1% year-over-year, despite a 4.9% year-over-year decline 
      in the fiscal fourth quarter due to mix. 
 
   --  Net dollar retention of 114.0% driven by inclusive access upsell and 
      cross--sell opportunities. 
 
   --  Evergreen delivery model continues to scale, representing 68% of Higher 
      Education revenue. 

K-12

   --  Performance exceeded expectations despite the smaller expected K--12 
      market opportunity driven by procurement cycles. 
 
   --  Fiscal Year 2026 revenue totaled $884.5 million, down 8.9% 
      year-over-year and 10.4% in fiscal fourth quarter given the cyclical 
      market comparison and higher capture rates last year. 
 
   --  Fiscal Year 2026 re-occurring revenue totaled $619.7 million, an 
      increase of 2.9% year-over-year, despite a 2.9% decline in the fiscal 
      fourth quarter, on strong market capture and robust prior year sales. 
 
   --  Early 2026--2027 selling season indicators support fiscal year 2027 as 
      the start of a multi-year market expansion opportunity, with trends that 
      vary by market. 
 
   --  Well-positioned for multi--year growth via nationwide Science of 
      Reading refresh, with strong early momentum from our Emerge, Summit, and 
      Soar curriculum. 

Global Professional and International

   --  Global Professional delivered 4.0% digital growth in fiscal year 2026, 
      driven by AI-powered medical solutions built on a foundation of trusted 
      content. 
 
   --  International revenue declined 7.3% in fiscal year 2026, with market 
      headwinds giving way to new commercial opportunities in key markets and 
      ALEKS Calculus expanding globally. 

Fiscal Year 2027 Guidance

The following fiscal year 2027 guidance is forward-looking, and is based on the Company's current expectations. Actual results may differ materially from what is indicated below.

 
                           Fiscal Year 2027 Guidance 
                        ------------------------------- 
                              As of June 11, 2026 
                        ------------------------------- 
($ in millions)               Low             High 
---------------------   ---------------  -------------- 
Revenue                   $       2,115   $       2,175 
Re-occurring Revenue              1,587           1,627 
Adjusted EBITDA (1)                 750             790 
 

Share Repurchase Plan

On June 2, 2026, our Board of Directors approved a share repurchase plan whereby, from time to time, the Company may repurchase up to $50 million of the Company's common stock.

Earnings Conference Call and Webcast

Today, June 11, 2026, at 8:30 a.m. ET, McGraw Hill will host a conference call via webcast to review fiscal year 2026 fourth quarter and full year results and provide a business update. The webcast will be hosted by Simon Allen, Chair of the Board of Directors, Philip Moyer, President and Chief Executive Officer, and Bob Sallmann, Executive Vice President and Chief Financial Officer, and will conclude with a question-and-answer session.

To access the live webcast or to view a replay, visit the Company's investor relations website at https://investors.mheducation.com/

The live question and answer portion of the call can be accessed by registering online at the Event Registration Page at which time registrants will receive dial-in information as well as a conference ID. Registration can be completed in advance of the conference call.

About McGraw Hill

McGraw Hill (NYSE: MH) is a leading global provider of education solutions for preK-12, higher education and professional learning, supporting the evolving needs of millions of educators and students around the world. We provide trusted, high-quality content and personalized learning experiences that use data, technology and learning science to help students progress towards their goals. Through our commitment to fostering a culture of innovation and belonging, we are dedicated to improving outcomes and access to education for all. We have over 30 offices across North America, Asia, Australia, Europe, the Middle East and South America, and make our learning solutions available in more than 80 languages. The Company's fiscal year is the 52-week period ended March 31. Visit us at mheducation.com or find us on Facebook, Instagram, LinkedIn or X.

Safe Harbor Statement

This press release includes statements that are, or may be deemed to be, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by the use of forward-looking terminology, including terms such as "believes," "estimates," "anticipates," "expects," "projects," "intends," "plans," "may," "will," "should" or "seeks," or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include, but are not limited to, statements regarding the Company's intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial condition, liquidity, prospects, growth, strategies and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties, as they relate to events and depend on circumstances that may or may not occur in the future. The Company's expectations, beliefs and projections are expressed in good faith, and the Company believes there is a reasonable basis for them; however, the Company cautions readers that forward-looking statements are not guarantees of future performance and that the Company's actual results of operations, financial condition and liquidity, and the developments in the industry in which the Company operates, may differ materially from those made in or suggested by the forward-looking statements contained in this press release. There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from the forward-looking statements contained in this press release, including those described under the headings "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, and in other filings made with the U.S. Securities and Exchange Commission. In addition, even if our results of operations, financial condition and liquidity, and the developments in the industry in which we operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. Any forward-looking statements the Company makes in this press release speak only as of the date of such statement. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities law.

(1) Non-GAAP Financial Measures

In addition to presenting financial results that have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), we have included in this release the following non-GAAP financial measures--EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted net income (loss), Adjusted basic and diluted earnings (loss) per share, Adjusted operating and administrative expenses, Adjusted selling and marketing expenses, Adjusted general and administrative expenses, Adjusted research and development expenses and Net Leverage Ratio. All such financial measures are not required by or presented in accordance with GAAP. We believe that these non-GAAP financial measures are useful in evaluating our business and the underlying trends that affect our performance. The Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. We include these non-GAAP financial measures in this release because management uses them to assess our performance. We believe that they reflect the underlying trends and indicators of our business and allow management to focus on the most meaningful indicators of our continuous operational performance. Although we believe these measures are useful for investors for the same reasons, readers of the financial statements herein should note that these measures are not a substitute for GAAP financial measures or disclosures. Each of these measures is not a recognized term under GAAP and does not purport to be an alternative to net income (loss), or any other measure derived in accordance with GAAP as a measure of operating performance, or to cash flows from operations as a measure of liquidity. Such measures are presented for supplemental information purposes only, have limitations as analytical tools and should not be considered in isolation or as substitute measures for our results as reported under GAAP. Management uses non-GAAP financial measures to supplement GAAP results to provide a more complete understanding of the factors and trends affecting our business, rather than evaluating GAAP results alone. Because not all companies use identical calculations, our measures may not be comparable to other similarly titled measures of other companies, and our use of these measures varies from others in our industry. Such measures are not intended to be a measure of cash available for management's discretionary use, as they may not capture actual cash obligations associated with interest payments, other debt service requirements and taxes. Because of these limitations, we rely primarily on our GAAP results and use these non-GAAP measures only supplementally. See "Reconciliations of Non-GAAP Financial Measures" in the "Supplemental Information" section below and "Management's Discussion and Analysis of Financial Condition and Results of Operations--Non-GAAP Financial Measures" in our Annual Report on Form 10-K filed on June 11, 2026, for reconciliations of non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP.

(2) Learning interactions measures the volume of user-driven educational activities across McGraw Hill platforms, including answering questions, completing assignments, and engaging with learning content. This data captures activity across K-12 platforms (Open Learning, ConnectED, ALEKS), Higher Education (Smartbook, Connect), and Enterprise IDM. For the fiscal year ended March 31, 2026, coverage expanded to include A3K Literacy, Actively Learn, and additional Connect data.

Forward-Looking Non-GAAP Financial Measures

This press release contains forward-looking estimates of Adjusted EBITDA for fiscal year 2027. We provide this non-GAAP measure to investors on a prospective basis for the same reasons (as set forth above) that we provide it to investors on a historical basis. We are unable to provide a reconciliation of our forward-looking estimate of fiscal year 2027 net income (loss) to a forward-looking estimate of fiscal year 2027 Adjusted EBITDA because certain information needed to make a reasonable forward-looking estimate of net income (loss) for fiscal year 2027 is unreasonably difficult to predict and estimate and is often dependent on future events that may be uncertain or outside of our control. In addition, we believe such reconciliations would imply a degree of precision that would be confusing or misleading to investors. The unavailable information could have a significant impact on our future financial results. Our forward-looking estimates of both GAAP and non-GAAP measures of our financial performance may differ materially from our actual results and should not be relied upon as statements of fact.

 
 
                    MCGRAW HILL, INC. AND SUBSIDIARIES 
                  CONSOLIDATED STATEMENTS OF OPERATIONS 
        (Dollars in thousands, except for share and per share data) 
 
                           Three Months Ended 
                                March 31,          Year Ended March 31, 
                          ---------------------  ------------------------- 
                            2026        2025        2026        2025 
                           -------    --------    ---------   --------- 
                               (unaudited) 
                          --------------------- 
Revenue                   $463,722   $ 473,262   $2,102,781  $2,101,299 
Cost of sales (excluding 
 depreciation and 
 amortization)              74,834      78,393      401,139     422,294 
                           -------    --------    ---------   --------- 
Gross profit               388,888     394,869    1,701,642   1,679,005 
Operating expenses 
Operating and 
 administrative 
 expenses                  282,023     292,535    1,080,250   1,066,496 
Depreciation                19,767      16,240       81,985      66,688 
Amortization of 
 intangibles                54,460      58,322      223,627     239,014 
Impairment charge           39,000          --       39,000          -- 
                           -------    --------    ---------   --------- 
      Total operating 
       expenses            395,250     367,097    1,424,862   1,372,198 
                           -------    --------    ---------   --------- 
Operating income (loss)     (6,362)     27,772      276,780     306,807 
                           -------    --------    ---------   --------- 
Interest expense 
 (income), net              45,154      63,547      207,226     293,446 
(Gain) loss on 
 extinguishment of debt      1,222          --       25,766       2,719 
                           -------    --------    ---------   --------- 
   Income (loss) from 
    operations before 
    taxes                  (52,738)    (35,775)      43,788      10,642 
Income tax provision 
 (benefit)                  (2,471)    121,092        8,468      96,481 
                           -------    --------    ---------   --------- 
Net income (loss)         $(50,267)  $(156,867)  $   35,320  $  (85,839) 
                           =======    ========    =========   ========= 
 
Basic earnings (loss) 
 per share                $  (0.26)  $   (0.94)  $     0.19  $    (0.52) 
Diluted earnings (loss) 
 per share                $  (0.26)  $   (0.94)  $     0.19  $    (0.52) 
 
 
__________________ 
(1) See "Supplemental Information--Reconciliations of Non-GAAP Financial 
Measures; Non-GAAP operating and administrative expenses" for a breakdown of 
our GAAP operating and administrative expenses and a reconciliation to the 
corresponding Non-GAAP financial measure. 
 
 
 
                    MCGRAW HILL, INC. AND SUBSIDIARIES 
                       CONSOLIDATED BALANCE SHEETS 
               (Dollars in thousands, except for share data) 
 
                                       March 31, 2026     March 31, 2025 
                                      ----------------  ------------------ 
Assets 
Current assets 
   Cash and cash equivalents           $      253,519    $      389,830 
   Accounts receivable, net of 
    allowance for credit losses of 
    $14,517 and $13,521 as of March 
    31, 2026 and 2025, respectively           362,483           338,426 
   Inventories, net                           195,022           174,018 
   Prepaid and other current assets           162,625           150,357 
                                          -----------       ----------- 
   Total current assets                       973,649         1,052,631 
   Product development costs, net             285,970           222,182 
   Property, plant and equipment, 
    net                                        90,421            95,197 
   Goodwill                                 2,522,595         2,557,595 
   Other intangible assets, net             1,227,253         1,454,185 
   Deferred income taxes                        8,572             7,983 
   Operating lease right-of-use 
    assets                                     44,836            49,661 
   Other non-current assets                   332,225           318,326 
                                          -----------       ----------- 
Total assets                           $    5,485,521    $    5,757,760 
                                          ===========       =========== 
Liabilities and stockholders' equity 
(deficit) 
Current liabilities 
   Accounts payable                    $      126,701    $      146,742 
   Accrued royalties                           81,436            71,457 
   Accrued compensation                       108,434           124,954 
   Deferred revenue                           835,357           794,031 
   Current portion of long-term debt           13,170            13,170 
   Operating lease liabilities                  8,365             8,042 
   Other current liabilities                   93,086           172,023 
                                          -----------       ----------- 
   Total current liabilities                1,266,549         1,330,419 
   Long-term debt                           2,560,698         3,164,551 
   Deferred income taxes                       15,214            15,656 
   Long-term deferred revenue                 836,001           882,156 
   Operating lease liabilities                 57,301            64,737 
   Other non-current liabilities               23,540            19,997 
                                          -----------       ----------- 
      Total liabilities                     4,759,303         5,477,516 
Commitments and contingencies 
Stockholders' equity (deficit) 
   Class A voting common stock, par 
    value $0.01 per share; 
    186,471,212 shares authorized, 
    165,160,216 shares issued and 
    outstanding as of March 31, 
    2025                                           --             1,652 
   Class B non-voting common stock, 
    par value $0.01 per share; 
    14,384,922 shares authorized, 
    1,451,303 shares issued and 
    outstanding as of March 31, 
    2025                                           --                14 
   Common Stock, par value $0.01 per 
   share; 2,000,000,000 shares 
   authorized, 191,146,027 shares 
   issued and outstanding as of 
   March 31, 2026; and no shares 
   authorized, issued and 
   outstanding as of March 31, 2025             1,911                -- 
   Additional paid-in capital               1,972,702         1,562,204 
   Accumulated deficit                     (1,245,880)       (1,281,200) 
   Accumulated other comprehensive 
    income (loss)                              (2,515)           (2,426) 
                                          -----------       ----------- 
      Total stockholders' equity 
       (deficit)                              726,218           280,244 
                                          -----------       ----------- 
Total liabilities and stockholders' 
 equity (deficit)                      $    5,485,521    $    5,757,760 
                                          ===========       =========== 
 
 
 
                     MCGRAW HILL, INC. AND SUBSIDIARIES 
                   CONSOLIDATED STATEMENTS OF CASH FLOWS 
                           (Dollars in thousands) 
 
                              Three Months Ended 
                                  March 31,           Year Ended March 31, 
                            ----------------------  ------------------------ 
                               2026        2025        2026        2025 
                             --------    --------    --------    -------- 
                                 (unaudited) 
                            ---------------------- 
Operating activities 
Net income (loss)           $ (50,267)  $(156,867)  $  35,320   $ (85,839) 
Adjustments to reconcile 
net income (loss) to net 
cash provided by operating 
activities 
  Depreciation (including 
   amortization of 
   technology costs)           19,767      16,240      81,985      66,688 
  Amortization of 
   intangibles                 54,460      58,322     223,627     239,014 
  Amortization of product 
   development costs           11,344      11,952      56,306      56,655 
  Amortization of deferred 
   royalties                    8,532      10,639      76,186      75,919 
  Amortization of deferred 
   commission costs             6,466       6,357      22,449      19,092 
  Stock-based compensation      1,986          --      33,723          -- 
  Credit losses on 
   accounts receivable          2,838       5,324       2,309       2,768 
  Unrealized (gain) loss 
   on interest rate cap            --          --          --         235 
  Inventory obsolescence          886       3,229       9,186      13,013 
  Deferred income taxes        (1,900)       (286)     (1,055)     (1,470) 
  Amortization of debt 
   discount                     3,053       5,733      13,000      20,722 
  Amortization of deferred 
   financing costs              1,199       1,713       4,943      10,495 
  (Gain) loss on 
   extinguishment of debt       1,222          --      25,766       2,719 
  Impairment charge            39,000          --      39,000          -- 
Changes in operating 
assets and liabilities: 
  Accounts receivable        (123,535)    (12,057)    (22,902)    (12,490) 
  Inventories                 (26,335)    (25,697)    (29,467)     26,299 
  Prepaid and other 
   current assets             (35,152)     27,618    (127,979)    (99,627) 
  Accounts payable and 
   accrued expenses             4,003      45,389     (21,265)     85,541 
  Deferred revenue            (25,138)    (72,011)     (6,174)    166,550 
  Other current 
   liabilities                (42,069)     16,201     (84,192)     46,854 
  Other changes in 
   operating assets and 
   liabilities, net             3,516      17,016         407      13,146 
                             --------    --------    --------    -------- 
       Cash provided by 
        (used for) 
        operating 
        activities           (146,124)    (41,185)    331,173     646,284 
                             --------    --------    --------    -------- 
Investing activities 
Product development 
 expenditures                 (42,321)    (29,524)   (119,001)    (90,000) 
Capital expenditures          (23,823)    (28,441)    (84,862)    (71,062) 
Acquisition of EssayPop            --      (6,000)         --      (6,000) 
                             --------    --------    --------    -------- 
   Cash provided by (used 
    for) investing 
    activities                (66,144)    (63,965)   (203,863)   (167,062) 
                             --------    --------    --------    -------- 
Financing activities 
Borrowings on 2024 Secured 
 Notes                             --          --          --     650,000 
Payment of A&E Term Loan 
 Facility                     (10,000)    (53,293)   (605,575)   (156,585) 
Payment of Term Loan 
 Facility                          --          --          --    (754,875) 
Repurchase of 2022 
 Unsecured Notes              (39,895)         --     (39,895)         -- 
Payment of deferred 
 financing costs                   --          --          --     (24,027) 
Payment of finance lease 
 obligations                     (810)     (1,485)     (6,722)     (9,193) 
Proceeds from issuance of 
common stock in Initial 
Public Offering, net of 
underwriting discounts             --          --     392,862          -- 
Deferred Initial Public 
 Offering costs                    --          --      (7,037)         -- 
Issuance of Common Stock        1,500          --       1,500          -- 
                             --------    --------    --------    -------- 
   Cash provided by (used 
    for) financing 
    activities                (49,205)    (54,778)   (264,867)   (294,680) 
                             --------    --------    --------    -------- 
Effect of exchange rate 
 changes on cash                  600         774       1,246       1,670 
                             --------    --------    --------    -------- 
Net change in cash and 
 cash equivalents            (260,873)   (159,154)   (136,311)    186,212 
Cash and cash equivalents, 
 at the beginning of the 
 period                       514,392     548,984     389,830     203,618 
                             --------    --------    --------    -------- 
Cash and cash equivalents, 
 at the end of the period   $ 253,519   $ 389,830   $ 253,519   $ 389,830 
                             ========    ========    ========    ======== 
Supplemental disclosures 
   Cash paid for interest 
    expense                 $  83,253   $ 101,338   $ 207,932   $ 274,730 
   Cash paid for income 
    taxes                       2,750      13,519      76,582      46,920 
 

Supplemental Information

Reconciliations of Non-GAAP Financial Measures

EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

"EBITDA" is defined as net income (loss) from continuing operations plus interest expense (income), net, income tax provision (benefit), depreciation and amortization.

"Adjusted EBITDA" is defined as net income (loss) from continuing operations plus interest expense (income), net, income tax provision (benefit), depreciation and amortization, restructuring and cost savings implementation charges, the effects of the application of purchase accounting, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), impairment charges, transaction and integration costs, stock-based compensation, (gain) loss on extinguishment of debt and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

Further, although not included in the calculation of Adjusted EBITDA below, we may at times add estimated cost savings and operating synergies related to operational changes ranging from acquisitions or dispositions to restructurings, and exclude one-time transition expenditures.

"Adjusted EBITDA Margin" is calculated by dividing Adjusted EBITDA by total revenue.

The following table presents a reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin to the most directly comparable GAAP financial measure for the periods presented.

 
                     Three Months Ended March 
                                31,                   Year Ended March 31, 
                    ---------------------------  ------------------------------ 
                      2026           2025           2026            2025 
                     -------       --------       ---------       --------- 
($ in thousands)            (unaudited) 
-----------------   ---------------------------  --------------  -------------- 
Net income (loss)   $(50,267)     $(156,867)     $   35,320      $  (85,839) 
Interest expense 
 (income), net        45,154         63,547         207,226         293,446 
Income tax 
 provision 
 (benefit)            (2,471)       121,092           8,468          96,481 
Depreciation, 
 amortization and 
 product 
 development 
 amortization         85,571         86,514         361,918         362,357 
                     -------       --------       ---------       --------- 
EBITDA              $ 77,987      $ 114,286      $  612,932      $  666,445 
Restructuring and 
 cost savings 
 implementation 
 charges (a)           2,402          7,616          11,176          24,626 
Advisory fees (b)         --          2,500           3,125          10,000 
Impairment charge 
 (c)                  39,000             --          39,000              -- 
Transaction and 
 integration costs 
 (d)                     373            462           1,191           2,982 
Stock-based 
 compensation (e)      1,986             --          33,723              -- 
Gain (loss) on 
 extinguishment of 
 debt (f)              1,222             --          25,766           2,719 
Other (g)              7,605          6,787          17,351          20,018 
                     -------       --------       ---------       --------- 
Adjusted EBITDA 
 (h)                $130,575      $ 131,651      $  744,264      $  726,790 
                     =======       ========       =========       ========= 
 
Total Revenue       $463,722      $ 473,262      $2,102,781      $2,101,299 
Net income (loss) 
 margin                (10.8)%        (33.1)%           1.7%           (4.1)% 
Adjusted EBITDA 
 Margin                 28.2%          27.8%           35.4%           34.6% 
 
 
__________________ 
(a) Represents severance and other expenses associated with headcount 
reductions and other cost savings initiated as part of our restructuring 
initiatives. 
(b) For the fiscal year ended March 31, 2026, represents the pro rata portion 
of the annual $10.0 million advisory fee paid to Platinum Advisors pursuant to 
the Advisory Agreement through its termination on July 25, 2025 in connection 
with the consummation of our initial public offering. For the fiscal year 
ended March 31, 2025, represents $10.0 million of annual advisory fees paid to 
Platinum Advisors pursuant to the Advisory Agreement. For the three months 
ended March 31, 2025, represents the quarterly portion of such annual advisory 
fee. 
(c) For the three months ended March 31, 2026 and the fiscal year ended March 
31, 2026, we recorded an impairment charge of $39.0 million, related to our 
International goodwill and indefinite-lived intangible trademark. 
(d) This primarily represents transaction and integration costs associated 
with acquisitions. 
(e) Represents stock-based compensation expense related to awards granted to 
our employees, directors and consultants under the Company's long-term 
incentive plans. 
(f) For the three months ended March 31, 2026, the amount represents 
accelerated amortization of debt discount and deferred financing costs 
associated with the repayment of $40.0 million face value of the 2022 
Unsecured Notes and $6.7 million of debt outstanding under the A&E Term Loan 
Facility. 
For the fiscal year ended March 31, 2026, the amount represents accelerated 
amortization of debt discount and deferred financing costs related to (i) the 
repayment of $385.7 million of debt outstanding under the A&E Term Loan 
Facility using net proceeds from our initial public offering on July 25, 2025, 
(ii) the repayment of an additional $206.7 million of debt outstanding under 
the A&E Term Loan Facility during the second half of fiscal year 2026, and 
(iii) the repayment of $40.0 million face value of the 2022 Unsecured Notes 
during the fourth fiscal quarter of 2026. 
For the fiscal year ended March 31, 2025, the amount represents accelerated 
amortization of debt discount and deferred financing costs associated with the 
August 6, 2024 refinancing of the Term Loan Facility. 
(g) For the three months ended March 31, 2026 and 2025, this amount represents 
(i) foreign currency exchange transaction impact of $(0.1) million and $(0.3) 
million, respectively, (ii) non-recurring expenses related to strategic 
initiatives, including marketing, consulting, and non-operational costs 
associated with the market introduction of a new product launch of $3.7 
million and $1.2 million, respectively, (iii) reimbursements of expenses paid 
to Platinum Advisors incurred in connection with its services under the 
Advisory Agreement (which was terminated on July 25, 2025 in connection with 
the consummation of our initial public offering) of $0.5 million and $0.2 
million, respectively, (iv) non-recurring transaction-related costs associated 
with our initial public offering that were expensed as incurred of nil and 
$1.8 million, respectively, (v) lease termination costs of nil and $3.3 
million, respectively, associated with the early exit of a leased property in 
connection with the strategic rationalization of our real estate properties to 
optimize cost efficiency, and (vi) the impact of additional insignificant 
earnings or charges resulting from matters that we do not consider indicative 
of our ongoing operations of $3.5 million and $0.6 million, respectively, that 
are primarily related to individually insignificant miscellaneous items, 
including third-party consulting and advisory fees associated with system and 
process rationalization initiatives and certain additional payments related to 
incremental insurance premiums and policies as a result of the Platinum 
acquisition that did not renew after the consummation of our initial public 
offering. 
For the fiscal years ended March 31, 2026 and 2025, the amount represents (i) 
foreign currency exchange transaction impact of $(2.3) million and $1.3 
million, respectively, (ii) non-recurring expenses related to strategic 
initiatives, including marketing, consulting, and non-operational costs 
associated with the market introduction of a new product launch of $9.2 
million and $4.3 million, respectively, (iii) reimbursements of expenses paid 
to Platinum Advisors incurred in connection with its services under the 
Advisory Agreement (which was terminated on July 25, 2025 in connection with 
the consummation of our initial public offering) of $0.8 million and $0.6 
million, respectively, (iv) non-recurring transaction-related costs associated 
with our initial public offering that were expensed as incurred of $2.8 
million and $4.9 million, respectively, (v) lease termination costs of nil and 
$3.3 million, respectively, associated with the early exit of a leased 
property in connection with the strategic rationalization of our real estate 
properties to optimize cost efficiency, (vi) post-acquisition compensation 
expense of nil and $0.6 million, respectively, associated with the acquisition 
of Boards & Beyond, and (vii) the impact of additional insignificant earnings 
or charges resulting from matters that we do not consider indicative of our 
ongoing operations of $6.9 million and $5.0 million, respectively, primarily 
related to individually insignificant miscellaneous items, including asset 
dispositions, third-party consulting and advisory fees associated with system 
and process rationalization initiatives, as well as certain additional 
payments related to incremental insurance premiums and policies as a result of 
the Platinum acquisition that did not renew after the consummation of our 
initial public offering. 
(h) The purchase accounting adjustment included in the definition of Adjusted 
EBITDA is not presented in the table above, as there were no such charges 
recognized during the three months ended March 31, 2026 and 2025 and the 
fiscal years ended March 31, 2026 and 2025. 
 

Adjusted net income (loss) and Adjusted basic and diluted earnings (loss) per share

"Adjusted net income (loss)" is defined as net income (loss) from continuing operations adjusted to exclude amortization of intangible assets, restructuring and cost savings implementation charges, the effects of the application of purchase accounting, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), impairment charges, transaction and integration costs, stock-based compensation, (gain) loss on extinguishment of debt and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations and the related tax impact of those adjustments.

"Adjusted basic and diluted earnings (loss) per share" is calculated by dividing Adjusted net income (loss) by the basic and diluted weighted average shares outstanding.

The following table presents a reconciliation of Adjusted net income (loss) and Adjusted basic and diluted earnings (loss) per share to the most directly comparable GAAP financial measure for the periods presented.

 
                    Three Months Ended March 31,       Year Ended March 31, 
                    ----------------------------  ------------------------------ 
                        2026           2025           2026           2025 
                     -----------    -----------    -----------    ----------- 
($ in thousands)            (unaudited) 
-----------------   ---------------------------- 
Net income (loss)   $    (50,267)  $   (156,867)  $     35,320   $    (85,839) 
Amortization of 
 intangible assets 
 (1)                      54,298         58,125        222,932        238,240 
Restructuring and 
 cost savings 
 implementation 
 charges (2)               2,402          7,616         11,176         24,626 
Advisory fees (2)             --          2,500          3,125         10,000 
Impairment charge 
 (2)                      39,000             --         39,000             -- 
Transaction and 
 integration costs 
 (2)                         373            462          1,191          2,982 
Stock-based 
 compensation (2)          1,986             --         33,723             -- 
Gain (loss) on 
 extinguishment of 
 debt (2)                  1,222             --         25,766          2,719 
Other (2)                  7,605          6,787         17,351         20,018 
Tax impact of 
 adjustments(3)            4,548       (246,707)       (14,125)       (10,396) 
                     -----------    -----------    -----------    ----------- 
Adjusted net 
 income (loss)      $     61,167   $   (328,084)  $    375,459   $    202,350 
                     ===========    ===========    ===========    =========== 
 
Basic earnings 
 (loss) per share   $      (0.26)  $      (0.94)  $       0.19   $      (0.52) 
Diluted earnings 
 (loss) per share   $      (0.26)  $      (0.94)  $       0.19   $      (0.52) 
Adjusted basic 
 earnings (loss) 
 per share          $       0.32   $      (1.97)  $       2.05   $       1.21 
Adjusted diluted 
 earnings (loss) 
 per share(4)       $       0.32   $      (1.97)  $       2.04   $       1.21 
Basic 
 weighted-average 
 shares 
 outstanding         191,066,548    166,611,519    183,466,677    166,611,519 
Diluted 
 weighted-average 
 shares 
 outstanding         191,066,548    166,611,519    183,670,022    166,611,519 
 
 
_____________ 
(1) Represents amortization of definite-lived acquired intangible assets. 
(2) Represents the same adjustments used in calculating EBITDA and Adjusted 
EBITDA. 
(3) Represents the tax impact of these adjustments, which are pre-tax, based 
upon the effective income tax rate. 
(4) For the three months ended March 31, 2026, the Company reported a net loss 
and, accordingly, all potentially dilutive securities were considered 
anti-dilutive and excluded from the calculation of diluted earnings (loss) per 
share. However, because the Company reported Adjusted net income for the same 
period, these potentially dilutive securities were included in the calculation 
of Adjusted diluted earnings (loss) per share, resulting in diluted 
weighted-average shares outstanding of 191,105,182. There were no potentially 
dilutive securities issued during the three months ended March 31, 2025. 
 

Non-GAAP operating and administrative expenses

"Adjusted operating and administrative expenses" is defined as GAAP operating and administrative expenses adjusted to exclude restructuring and cost savings implementation charges, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), transaction and integration costs, stock-based compensation, amortization of product development costs and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

"Adjusted selling and marketing expenses" is defined as GAAP selling and marketing expenses adjusted to exclude stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

"Adjusted general and administrative expenses" is defined as GAAP general and administrative expenses adjusted to exclude restructuring and cost savings implementation charges, advisory fees paid to Platinum Advisors pursuant to the Advisory Agreement (which was terminated on July 25, 2025 in connection with the consummation of our initial public offering), transaction and integration costs, stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

"Adjusted research and development expenses" is defined as GAAP research and development expenses adjusted to exclude stock-based compensation and the impact of earnings or charges resulting from matters that we do not consider indicative of our ongoing operations.

The following table presents a reconciliation of these non-GAAP operating and administrative expenses to the most directly comparable GAAP financial measure for the periods presented.

 
                      Three Months Ended 
                          March 31,           Year Ended March 31, 
                     --------------------  -------------------------- 
                       2026       2025        2026         2025 
                      -------    -------    ---------    --------- 
($ in thousands)         (unaudited) 
------------------   -------------------- 
Operating and 
 administrative 
 expenses            $282,023   $292,535   $1,080,250   $1,066,496 
Restructuring and 
 cost savings 
 implementation 
 charges               (2,402)    (7,616)     (11,176)     (24,626) 
Advisory fees              --     (2,500)      (3,125)     (10,000) 
Transaction and 
 integration costs       (373)      (462)      (1,191)      (2,982) 
Amortization of 
 product 
 development costs    (11,344)   (11,952)     (56,306)     (56,655) 
Stock-based 
 compensation          (1,986)        --      (33,723)          -- 
Other                  (7,605)    (6,787)     (17,351)     (20,018) 
                      -------    -------    ---------    --------- 
Adjusted operating 
 and administrative 
 expenses (1)        $258,313   $263,218   $  957,378   $  952,215 
                      =======    =======    =========    ========= 
 
Selling and 
 marketing           $101,565   $104,375   $  378,719   $  380,199 
   Stock-based 
    compensation          (19)        --       (1,180)          -- 
   Other               (2,856)      (743)      (6,922)      (3,210) 
                      -------    -------    ---------    --------- 
Adjusted selling 
 and marketing 
 expenses (1)        $ 98,690   $103,632   $  370,617   $  376,989 
                      =======    =======    =========    ========= 
 
General and 
 administrative      $ 95,485   $ 88,853   $  368,972   $  345,213 
   Restructuring 
    and cost 
    savings 
    implementation 
    charges            (2,402)    (7,616)     (11,176)     (24,626) 
   Advisory fees           --     (2,500)      (3,125)     (10,000) 
   Transaction and 
    integration 
    costs                (373)      (462)      (1,191)      (2,982) 
   Stock-based 
    compensation       (1,919)        --      (27,428)          -- 
   Other               (4,010)    (5,655)      (8,500)     (15,747) 
                      -------    -------    ---------    --------- 
Adjusted general 
 and administrative 
 expenses (1)        $ 86,781   $ 72,620   $  317,552   $  291,858 
                      =======    =======    =========    ========= 
 
Research and 
 development         $ 73,629   $ 87,355   $  276,253   $  284,429 
   Stock-based 
    compensation          (48)        --       (5,115)          -- 
   Other                 (739)      (389)      (1,929)      (1,061) 
                      -------    -------    ---------    --------- 
Adjusted research 
 and development 
 expenses (1)        $ 72,842   $ 86,966   $  269,209   $  283,368 
                      =======    =======    =========    ========= 
 
 
_____________ 
(1) We calculate each of these measures by using the same adjustments used in 
calculating EBITDA and Adjusted EBITDA to the extent such items are included 
in the corresponding GAAP operating and administrative expense category. 
 

Net Leverage Ratio

"Net Leverage Ratio" is calculated by dividing net debt as of the most recent balance sheet date by the Last Twelve Months ("LTM") Adjusted EBITDA. Net debt is defined as Gross Debt, net of cash and cash equivalents. Gross Debt is defined as the total amount of principal borrowings outstanding.

LTM is defined as the twelve-month period ended on the last day of the most recently completed fiscal quarter. LTM Adjusted EBITDA is equal to Adjusted EBITDA for the fiscal year ended March 31, 2026.

 
                                     As of March 31, 
                                   ------------------- 
($ in thousands)                           2026 
--------------------------------       ------------ 
A&E Term Loan Facility due 2031     $       554,840 
2022 Secured Notes due 2028                 828,466 
2024 Secured Notes due 2031                 650,000 
                                       ------------ 
First Lien Indebtedness             $     2,033,352 
2022 Unsecured Notes due 2029               599,034 
                                       ------------ 
Gross Debt                          $     2,632,386 
Cash and cash equivalents                  (253,519) 
                                       ------------ 
Net Debt                            $     2,378,867 
 
LTM Adjusted EBITDA (1)             $       744,264 
 
Net Leverage Ratio (2)                            3.2x 
 
 
__________ 
(1) LTM Adjusted EBITDA is equal to Adjusted EBITDA for the fiscal year ended 
March 31, 2026. 
(2) In addition to the Net Leverage Ratio, the Company is subject to a 
Consolidated First Lien Net Leverage Ratio springing covenant, pursuant to its 
credit agreement. The Consolidated First Lien Net Leverage Ratio is calculated 
by dividing Consolidated First Lien Secured Debt by LTM Consolidated Adjusted 
EBITDA, as such terms are defined in our credit agreements. As of March 31, 
2026, the Consolidated First Lien Net Leverage Ratio was 2.4x. The 
Consolidated First Lien Secured Debt was $1,795,896 as of March 31, 2026, and 
is defined as First Lien Indebtedness of $2,033,352 plus capital lease 
obligations of $16,063, net of cash and cash equivalents of $253,519. LTM 
Consolidated Adjusted EBITDA is Consolidated Adjusted EBITDA for the fiscal 
year ended March 31, 2026 of $751,803. Consolidated Adjusted EBITDA differs 
from Adjusted EBITDA presented elsewhere herein and is defined in our credit 
agreements. 
 

Key Operating Metrics

Re-occurring Revenue and Transactional Revenue

 
                                                    Three Months Ended March 31, 
                    -------------------------------------------------------------------------------------------- 
                                        2026                                           2025 
                    --------------------------------------------  ---------------------------------------------- 
                     Re-occurring     Transactional                Re-occurring     Transactional 
                        Revenue          Revenue         Total        Revenue          Revenue          Total 
                    --------------  -----------------  ---------  --------------  -----------------  ----------- 
($ in thousands)                    (unaudited)                                    (unaudited) 
-----------------   --------------------------------------------  ---------------------------------------------- 
  K-12                $    109,142   $   17,071        $126,213     $    112,384   $   28,446        $140,830 
  Higher Education         217,106       41,144         258,250          228,307       25,807         254,114 
  Global 
   Professional             25,141       13,729          38,870           24,480       13,876          38,356 
  International             22,110       18,705          40,815           21,839       21,186          43,025 
  Other                         --         (426)           (426)              --       (3,063)         (3,063) 
                    ---  ---------      -------   ---   -------   ---  ---------      -------   ---   ------- 
Total Revenue         $    373,499   $   90,223        $463,722     $    387,010   $   86,252        $473,262 
                    ===  =========      =======  ====   =======   ===  =========      =======  ====   ======= 
 
 
                                                        Year Ended March 31, 
                    --------------------------------------------------------------------------------------------- 
                                       2026                                            2025 
                    -------------------------------------------  ------------------------------------------------ 
                     Re-occurring    Transactional                Re-occurring     Transactional 
($ in thousands)        Revenue         Revenue        Total         Revenue          Revenue           Total 
-----------------   --------------  ---------------  ----------  --------------  -----------------  ------------- 
   K-12              $     619,725    $     264,755  $  884,480   $     602,040   $   368,444       $  970,484 
   Higher 
    Education              734,353          144,601     878,954         666,748       115,862          782,610 
   Global 
    Professional            98,746           51,330     150,076          95,094        54,494          149,588 
   International            88,143           98,542     186,685          92,959       108,443          201,402 
   Other                        --            2,586       2,586              --        (2,785)          (2,785) 
                        ----------  ---  ----------   ---------      ----------      --------        --------- 
Total Revenue        $   1,540,967    $     561,814  $2,102,781   $   1,456,841   $   644,458       $2,101,299 
                        ==========  ===  ==========   =========      ==========      ========  ===   ========= 
 

(MORE TO FOLLOW) Dow Jones Newswires

June 11, 2026 07:24 ET (11:24 GMT)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10